Afficher la notice abrégée

dc.contributor.authorMuñoz-Bravo, Carlos
dc.contributor.authorLozano Lorca, Macarena 
dc.contributor.authorKouiti, Malak
dc.contributor.authorGonzález-Palacios Torres, Carla
dc.contributor.authorBarrios Rodríguez, Rocío 
dc.contributor.authorJiménez Moleón, José Juan 
dc.date.accessioned2023-09-01T10:24:01Z
dc.date.available2023-09-01T10:24:01Z
dc.date.issued2023-06-27
dc.identifier.citationMuñoz-Bravo C, Soler-Iborte E, Lozano- Lorca M, Kouiti M, González-Palacios Torres C, Barrios-Rodríguez R and Jiménez-Moleón JJ (2023) Serum copper levels and risk of major adverse cardiovascular events: a systematic review and meta-analysis. Front. Cardiovasc. Med. 10:1217748. [doi: 10.3389/fcvm.2023.1217748]es_ES
dc.identifier.urihttps://hdl.handle.net/10481/84185
dc.description.abstractBackground: Despite the fact that several studies have investigated the association between serum copper levels (S-Cu) and the risk of cardiovascular diseases, this relationship remains unclear. The aims of this study were to investigate the association between S-Cu and risk of major adverse cardiovascular events (MACE), including total stroke, ischemic stroke, hemorrhagic stroke, myocardial infarction and cardiovascular mortality, and identify potential sources of results heterogeneity. Methods: We carried out a systematic review and meta-analysis. The selection criteria were: (1) Observational studies (cohort studies, case-control studies and hybrid studies); (2) Studies containing quantitative data about the relationship between S-Cu and risk of MACE; (3) Estimating association measures; and (4) Studies written in English, French or Spanish. Overall pooled Odds ratio (pOR) and 95% confidence intervals (95% CI) of MACE for the highest vs. lowest S-Cu category were calculated using random-effects models. Results: Sixteen studies with a total of 41,322 participants were included in the meta-analysis: 10 prospective cohort studies, 5 nested case-control studies and 1 case-control study. Comparing highest vs. lowest category, high S-Cu levels were associated with total stroke (pOR: 1.49, 95% CI 1.22–1.82; I2=0%, p=0.54), myocardial infarction (pOR: 1.31, 95% CI 1.17–1.46; I2=0.0%, p=0.92) and cardiovascular mortality (pOR: 1.60, 95% CI 1.39–1.86; I2=0.0%, p=0.54). Subgroup analysis showed that studies with a hybrid design had higher risks for cardiovascular mortality (pOR: 3.42, 95% CI 1.98–5.92) and ischemic stroke (pOR: 1.54, 95% CI 1.30–1.83). Conclusion: High S-Cu levels were associated with an increased risk of total stroke, myocardial infarction and cardiovascular mortality. Hybrid studies seems to modify the strength of the association between S-Cu and the risk of cardiovascular mortality and ischemic strokees_ES
dc.language.isoenges_ES
dc.publisherFrontierses_ES
dc.rightsAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectSerum copperes_ES
dc.subjectCardiovascular diseasees_ES
dc.subjectCardiovascular mortalityes_ES
dc.subjectStrokees_ES
dc.subjectMyocardial infarction es_ES
dc.subjectMeta-analysises_ES
dc.subjectCardiovascular eventses_ES
dc.titleSerum copper levels and risk of major adverse cardiovascular events: a systematic review and meta-analysises_ES
dc.typejournal articlees_ES
dc.rights.accessRightsopen accesses_ES
dc.identifier.doi10.3389/fcvm.2023.1217748
dc.type.hasVersionVoRes_ES


Fichier(s) constituant ce document

[PDF]

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée

Atribución 4.0 Internacional
Excepté là où spécifié autrement, la license de ce document est décrite en tant que Atribución 4.0 Internacional